Canada supports AstraZeneca-Oxford

Canada’s chief public health officer said today there is no evidence to suggest the AstraZeneca-Oxford COVID-19 vaccine is causing adverse events — and the vaccine’s benefits outweigh any risks. Dr. Theresa Tam told reporters at a media briefing that federal, provincial and territorial authorities are “continuously monitoring” vaccine safety after nearly a dozen European countries suspended the vaccine’s use in response to concerns about blood clots.

“Health Canada is aware of reports of serious adverse events in Europe following immunization with the AstraZeneca vaccine, but wants to reassure Canadians that the benefits of the vaccine continue to outweigh its risks,” she said.  “There is currently no indication that the vaccine caused the observed event.” To date, she added, “no unexpected vaccine safety issues have been identified in Canada.”